Reconsidering milrinone: Time to revive the oral form for drug repurposing?

Fatemeh Afra Department of Clinical Pharmacy, School of Pharmacy, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
Elahe Shaban Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Amirmahdi Mojtahedzadeh School of Medicine, Semmelweis University, Budapest, Hungary
Mojtaba Mojtahedzadeh Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

DOI: https://doi.org/10.18502/cjn.v24i3.21605

Keywords: Milrinone; Phosphodiesterase 3 Inhibitors; Neuroprotective Agents; Subarachnoid Hemorrhage

The Article Abstract is not available.